Breaking
$60M Series C closed October 2024 Available in all 50 states + D.C. 92% of patients report symptom improvement $10,292 saved per patient in six months 98% patient satisfaction $206.5M raised to date Backed by Oak HC/FT, CVS, Takeda, Bessemer $60M Series C closed October 2024 Available in all 50 states + D.C. 92% of patients report symptom improvement $10,292 saved per patient in six months 98% patient satisfaction $206.5M raised to date Backed by Oak HC/FT, CVS, Takeda, Bessemer
Company Profile - Digital Health

Oshi Health

The virtual GI clinic for the one in four Americans whose digestive system has its own opinions.

Founded 2020 New York, NY ~150 employees Series C
Oshi Health
Oshi Health, photographed in its natural habitat: the open graph card. The logo is calmer than the average gut it treats.
Dispatch - Who they are now

A doctor's office that fits inside a phone

Somewhere right now, a person is sitting on a bathroom floor at 2 a.m., googling symptoms that no search bar can fix. The traditional answer is a referral, a three-month wait, a fifteen-minute appointment, and a follow-up scheduled for never. Oshi Health decided that was an unacceptable answer.

Today Oshi is an in-network virtual gastrointestinal clinic available in all 50 states and Washington D.C., reachable by anyone whose health plan or employer has signed on - roughly 40 million people and counting. Open the app and you are not handed a chatbot. You are introduced to an actual team: a board-certified gastroenterologist, an advanced-practice provider, a registered dietitian, a behavioral-health specialist trained in the gut-brain connection, and a care coordinator who remembers your name. Visits are virtual. Messaging is unlimited. The wait is measured in days, not seasons.

"Bringing center-of-excellence quality GI care to people - wherever they are."

Sam Holliday, Co-Founder & CEO
50
States covered
92%
Symptom improvement
98%
Patient satisfaction
$10.3K
Saved / patient / 6mo
The problem they saw

Everyone has a gut. Almost nobody has good care for it.

Digestive disease is the condition polite society agreed not to discuss. That silence is expensive. Two out of three Americans report digestive symptoms in any given week. One in four lives with a diagnosed GI condition - Crohn's, ulcerative colitis, IBS, GERD, SIBO, or the vast grey country of "we ran tests and found nothing." The national bill runs past $136 billion a year.

The strange part is that the money is mostly wasted. Patients bounce between specialists, collect redundant scopes and scans, land in the ER when a flare hits at midnight, and rarely get the one thing that works: coordinated care that treats diet, behavior, and biology as a single problem. Gastroenterologists are scarce, booked, and paid to perform procedures - not to talk you through a low-FODMAP week or the anxiety that tightens your stomach. The system was built to find polyps, not to make people feel better.

"Two out of three Americans have weekly digestive symptoms. The care system has, charmingly, decided this is fine."

- The case Oshi was built to argue against
The founders' bet

An operator and a gastroenterologist walk into a clinic

Oshi began in 2020 with two people who saw the same problem from opposite ends. Sam Holliday had spent a decade scaling AOL, then crossed into value-based healthcare at Aledade, Avalere, and Audacious Inquiry before running the Florida market for one of the country's largest independent primary-care groups. He understood the unglamorous machinery of getting paid to keep people well. Dr. Sameer Berry is a gastroenterologist and physician-scientist with more than 25 peer-reviewed papers, who runs randomized controlled trials on digital health and alternative payment models. He understood the medicine, and the evidence required to prove it.

Their bet was contrarian in a sector addicted to shortcuts: build the clinical team in-house rather than renting a network of contractors, and refuse to launch a claim Oshi could not back with a study. Most digital-health startups grow first and gather evidence later, if ever. Oshi inverted it. The thesis was that rigorous, multidisciplinary, whole-person GI care would not only help patients but cost payers less - and that you could measure both.

Co-Founder & CEO

Sam Holliday

Ex-AOL operator turned value-based-care builder. Spent years on the business of keeping people healthy before deciding the gut deserved its own clinic.

Co-Founder & Chief Medical Officer

Dr. Sameer Berry

Gastroenterologist, physician-scientist, 25+ peer-reviewed papers. Named to Modern Healthcare's 50 Most Influential Clinical Executives.

"Building our own multidisciplinary clinical team is the bedrock of our outcomes."

Dr. Sameer Berry, Co-Founder & CMO
The product

One team. Every part of the problem.

Oshi's product is deceptively simple to describe and hard to copy: a virtual clinic where a single coordinated team treats the whole person. The gut-brain connection is not a marketing line here - the behavioral-health specialist is a core team member, because stress and digestion are not separate appointments. Diet is handled by a registered dietitian, not a pamphlet. And a gastroenterologist oversees it all, so the plan holds together.

Virtual GI Clinic

Diagnosis and treatment for IBS, IBD, GERD, SIBO, and undiagnosed symptoms - with unlimited virtual visits and messaging.

The Care Team

GI doctors, advanced-practice providers, dietitians, gut-brain specialists, and care coordinators - employed, not outsourced.

Whole-Person Model

Diet, behavior, medication, and biology treated together, integrated with your existing plan, employer, or local GI practice.

The story so far

Five years, one stubborn organ

  • 2020
    Oshi Health founded by Sam Holliday and Dr. Sameer Berry to bring multidisciplinary GI care online.
  • 2021
    $23M Series A - backed by Flare Capital, Bessemer, Frist Cressey, with strategic investment from CVS Health Ventures and Takeda.
  • 2023
    $30M Series B led by Koch Disruptive Technologies to scale access to virtual care.
  • 2024
    Reaches all 50 states + D.C.; named the first virtual GI center of excellence with national scale.
  • Oct 2024
    $60M Series C led by Oak HC/FT - reportedly unplanned, prompted by the outcomes data.
  • 2025
    Strategic investments from the American College of Gastroenterology and the American Gastroenterological Association.
The proof

The numbers did the fundraising

Most health-tech pitches lean on a hopeful slide. Oshi leaned on a clinical trial. In an analysis by a national health plan of a large commercially insured population, 92% of Oshi members reported symptom improvement and 98% reported satisfaction. The financial result was the one that made investors lean in: total medical-cost savings of $10,292 per patient over six months, driven by fewer avoidable scopes, scans, ER visits, and prescriptions. According to reporting, the Series C was not even planned - investors came knocking after seeing the data.

What changes when care is coordinated

Source: Oshi Health published outcomes / national health plan analysis
92%
Symptom
improvement
98%
Patient
satisfaction
$10.3K
Saved per
patient / 6mo
40M+
People with
in-network access
Bars scaled for readability; figures are the published values, not the pixel heights. The gut, mercifully, does not grade on a curve.

"A $60M round nobody set out to raise. The clinical evidence, it turns out, makes a persuasive cold email."

- On Oshi's 2024 Series C

The believers are telling. The cap table includes Oak HC/FT, CVS Health Ventures, Takeda Digital Ventures, Bessemer, Flare Capital, and Frist Cressey - and, unusually, the two largest U.S. gastroenterology societies, the American College of Gastroenterology and the American Gastroenterological Association. When the establishment of a medical specialty invests in a startup challenging how that specialty is delivered, it is worth noticing. Employer partners now include Dayforce, Koch Inc., Mariner, Nielsen, and TE Connectivity.

Series A - 2021
$23M
Flare, Bessemer, CVS, Takeda
Series B - 2023
$30M
Koch Disruptive Technologies
Series C - 2024
$60M
Oak HC/FT (lead)
The mission

Make the gut a covered, measurable standard

Oshi's stated aim is to increase access to high-quality, coordinated digestive care while lowering its total cost - and to prove both with evidence rather than assertion. The deeper ambition is structural. Oshi wants whole-person GI care to be normal: in-network, reimbursed, and held to the same outcomes bar as any center of excellence. The 2025 plan to expand into Medicare populations is the next test of whether the model travels beyond the commercially insured.

Watch & listen

See it in their own words

Why it matters tomorrow

Back to the bathroom floor, 2 a.m.

Return to that person, awake and afraid, scrolling for an answer. In the old story, they wait three months, get fifteen minutes, and learn nothing they can use that night. In Oshi's version, they message a care team that already knows their history, get a dietitian's plan and a clinician's reassurance within days, and stay out of the ER entirely. The flare still happens. What changes is whether anyone competent is there for it.

That is the whole argument, and Oshi has put numbers under it: 92% better, 98% satisfied, $10,000 saved, 50 states reached. Digestive disease will not be cured by an app, and Oshi does not pretend otherwise. But the quiet, expensive, embarrassing problem of American gut health finally has a clinic built around the patient instead of the procedure - and a balance sheet that says doing it right is also cheaper. The 2 a.m. floor is still cold. For a growing number of people, it is no longer lonely.

"The gut got a real doctor's office. It just happens to live in your pocket."

- Oshi Health, in one line